Halozyme Therapeutics HALO
NASDAQ HALO
$110.43 -1.13 (-1.01%)
As of: Sep 30, 2026 · 3:59 PM EDT

Halozyme Therapeutics (HALO) Total Debt (2013 - 2026)

Updated

Halozyme Therapeutics (HALO) posted Total Debt of $2.15 billion for Q2 2026, up 42.2% from $1.51 billion a year earlier and up 0.1% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Total Debt (2013 - 2026) Analysis & Trends

At the end of FY2025, Halozyme Therapeutics' Total Debt came in at $2.14 billion, up 42.3% from FY2024.

  • Annual Total Debt shows a five-year compound annual growth rate of 40.1% (FY2020 to FY2025).
  • In prior years, Halozyme Therapeutics' Total Debt was $1.51 billion in FY2024 (+0.4%), $1.5 billion in FY2023 (-0.5%), $1.51 billion in FY2022 (+71.8%) and $876.67 million in FY2021 (+120.7%).
  • The Q2 2026 figure stands as the highest quarterly Total Debt in data going back to Q1 2013.
  • On a year-over-year basis, Total Debt has increased in each of the last ten quarters, with growth averaging 16.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Debt in the past five years was Q4 2021, with growth of 120.7%; the weakest was Q3 2023, with a decline of 0.5%.
  • According to Business Quant data, Total Debt for the three prior quarters was $2.14 billion (Q1 2026), $2.14 billion (Q4 2025) and $1.51 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 49.04 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 70.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -111.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Halozyme Therapeutics 12.72 Bn 11.33 Bn 401.83 Mn 2.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.15 Bn
Mar 31, 2026 2.14 Bn
Dec 31, 2025 2.14 Bn
Sep 30, 2025 1.51 Bn
Jun 30, 2025 1.51 Bn
Mar 31, 2025 1.51 Bn
Dec 31, 2024 1.51 Bn
Sep 30, 2024 1.50 Bn
Jun 30, 2024 1.50 Bn
Mar 31, 2024 1.50 Bn
Dec 31, 2023 1.50 Bn
Sep 30, 2023 1.50 Bn
Jun 30, 2023 1.50 Bn
Mar 31, 2023 1.49 Bn
Dec 31, 2022 1.51 Bn
Sep 30, 2022 1.50 Bn
Jun 30, 2022 99.05 Mn
Mar 31, 2022 89.55 Mn
Dec 31, 2021 876.67 Mn
Sep 30, 2021 89.25 Mn
API Access

Halozyme Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=HALO&period=max&api_key=YOUR_API_KEY